Skip to main content
. Author manuscript; available in PMC: 2019 Jan 12.
Published in final edited form as: Circulation. 2016 May 5;133(22):2132–2140. doi: 10.1161/CIRCULATIONAHA.115.021168

Table 2.

Long-term outcomes with EES vs. CABG in the propensity score matched cohort

Variables No. of Patients No. of Events Event Rate* (4-year) Hazard Ratio (95% CI) P-value
 Outcome: Death
 EES 1063 185 25.22% 1.01 [0.81, 1.28] 0.91
 CABG 1063 196 21.03% Ref
 Outcome: MI
 EES 1063 87 11.28% 2.16 [1.42, 3.28] 0.0003
 CABG 1063 46 5.58% Ref
 Outcome: Stroke
 EES 1063 28 3.90% 0.57 [0.33, 0.97] 0.04
 CABG 1063 51 5.92% Ref
 Outcome: Revascularization
 EES 1063 180 22.27% 2.54 [1.88, 3.44] <0.0001
 CABG 1063 91 11.53% Ref
*

Event rates are based on 4 year Kaplan Meier estimates. CABG = coronary artery bypass graft surgery; EES = everolimus eluting stent